Markets
-
Jia Yueting Pledges “Shareholders and Investors First,” Aims for First Milestone in Personal Equity Incentive Plan
Jia Yueting, co-founder of Faraday Future (FF), reaffirmed his commitment to shareholders and investors. He aims to achieve the initial milestones of his equity incentive plan, linked to FF’s stock performance and market capitalization. FF announced pre-orders for its FX Super One and unveiled the design rendering of the FX4. Upcoming plans include launch events and expanding sales initiatives, with a focus on web3 collaborations and a rollout in the Middle East.
-
Top 10 “Made in China” Products Americans Depend On: Umbrellas at #3, the #1 Might Surprise You
A recent report reveals the significant dependence of U.S. consumers on Chinese-made goods. Highlighting items like baby strollers, artificial plants, and umbrellas, the study underscores China’s dominance in various consumer markets. An experiment demonstrated consumers’ preference for cheaper, Chinese-made products, even when an American-made alternative was available at a higher price. The article suggests a full transition away from Chinese imports is complex.
-
Musk Launches XChat: Encrypted Messaging, Audio/Video Calls, and Self-Destructing Messages
Elon Musk launched XChat, an encrypted messaging platform for X (formerly Twitter), featuring end-to-end encryption, self-destructing messages, file sharing, and audio/video calls without phone numbers. Built with Rust and “bitcoin-like” encryption, it aims to become an all-encompassing “everything app” like WeChat. Currently, XChat is available to select paying users and secured with a passcode, representing a major step in Musk’s broader strategy for the platform.
-
Faraday Future’s Inaugural Stockholders’ Day: FX Product Updates, FX Super One Launch Confirmed, and 600 New Deposits Secured from MCN Agencies
Faraday Future’s Stockholders’ Day highlighted its commitment to transparency and shareholder value. The FX Super One will launch with exclusive events in June and July, followed by a B2C rollout. The company has secured over 2,500 B2B pre-order deposits for the FX Super One, and unveiled the FX 4 design concept. FF is also expanding operations, including a new Middle East facility, and enhancing its tech and operational capabilities.
-
Google’s New App: AI on Your Phone, Offline Image Generation & Code Creation
Google launched the AI Edge Gallery, an app enabling on-device AI on smartphones. Sourced from Hugging Face, it allows users to run AI models offline with features like image-based question answering and text manipulation via a “Prompt Lab.” Performance varies based on device hardware and model size. The app is an experimental Alpha version, open-source under Apache 2.0, and encourages user feedback.
-
Hyundai Card First in Asia to Earn UL Solutions Healthy Building Verification for Cultural and Leisure Venues
Hyundai Card has earned the UL Verified Healthy Building Mark for four of its facilities in Seoul, becoming the first cultural and leisure buildings in Asia to receive this certification. This achievement highlights their dedication to employee and guest well-being through healthier and more sustainable indoor environments, evaluated for air and water quality, as well as overall indoor environment.
-
Trevi Therapeutics Announces Phase 2b CORAL Trial Topline Results for Haduvio in IPF Chronic Cough: Conference Call and Webcast Scheduled for June 2nd
Trevi Therapeutics will release topline results from its Phase 2b CORAL trial of Haduvio, an investigational therapy for chronic cough in idiopathic pulmonary fibrosis (IPF). A conference call and webcast will be held on June 2nd, 2025, at 8:30 a.m. ET to discuss the findings. Haduvio targets the cough reflex arc, and initial trials show promising reduction in cough frequency. The results are highly anticipated as there is currently no approved therapy for IPF chronic cough. Further information can be found on the company’s website.
-
Bicara Therapeutics Presents Positive Data for Ficerafusp Alfa Plus Pembrolizumab in First-Line HPV-Negative R/M HNSCC at ASCO 2025
Bicara Therapeutics presented positive Phase 1/1b trial data for ficerafusp alfa, a bifunctional antibody, combined with pembrolizumab in first-line recurrent/metastatic head and neck cancer. The results, particularly in HPV-negative patients, showed significant antitumor activity, including a median duration of response of 21.7 months, median overall survival of 21.3 months, and a two-year overall survival rate of 46%. The data supports the advancement of the FORTIFI-HN01 pivotal trial.
-
JD’s First 618 for Delivery: Over 1.5 Million Quality Merchants Join, Orders Surpass 25 Million Daily
JD.com’s food delivery service is celebrating its first 618 shopping festival, marking rapid growth. The platform, operating in 350 cities with over 100,000 riders, reports over 25 million daily orders, driven by 1.5 million restaurant partners. Stringent measures like video verification and a 40% new partner approval rate highlight its commitment to quality and safety, positioning it as a major player in the food delivery market.
-
Mountaineering Marvel for Seniors: A Field Study of the External Skeleton Robot on Mount Tai
Exoskeleton robots are revolutionizing Mount Tai climbs, with rentals surging, especially among older tourists. Partnering with *Technology company name*, the mountain uses these devices as a testbed, gathering data yielding product improvements. The devices significantly reduce strain and time, leading to growing demand and attracting investment from numerous companies. Future development prioritizes reduced weight, enhanced comfort, and broader consumer adoption, promising a vast market.